These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21448425)

  • 1. Strong expression of CD133 is associated with increased cholangiocarcinoma progression.
    Leelawat K; Thongtawee T; Narong S; Subwongcharoen S; Treepongkaruna SA
    World J Gastroenterol; 2011 Mar; 17(9):1192-8. PubMed ID: 21448425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of CD133+ parenchymal cells in the liver: histology and culture.
    Yoshikawa S; Zen Y; Fujii T; Sato Y; Ohta T; Aoyagi Y; Nakanuma Y
    World J Gastroenterol; 2009 Oct; 15(39):4896-906. PubMed ID: 19842219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD24 in cholangiocarcinoma cells is associated with disease progression and reduced patient survival.
    Keeratichamroen S; Leelawat K; Thongtawee T; Narong S; Aegem U; Tujinda S; Praditphol N; Tohtong R
    Int J Oncol; 2011 Oct; 39(4):873-81. PubMed ID: 21687942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.
    Shimada M; Sugimoto K; Iwahashi S; Utsunomiya T; Morine Y; Imura S; Ikemoto T
    J Gastroenterol; 2010 Aug; 45(8):896-902. PubMed ID: 20379837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.
    Thanan R; Pairojkul C; Pinlaor S; Khuntikeo N; Wongkham C; Sripa B; Ma N; Vaeteewoottacharn K; Furukawa A; Kobayashi H; Hiraku Y; Oikawa S; Kawanishi S; Yongvanit P; Murata M
    Free Radic Biol Med; 2013 Dec; 65():1464-1472. PubMed ID: 23917144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma.
    Chu X; Zhao P; Lv Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(1):328-36. PubMed ID: 25755719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma.
    Fan L; He F; Liu H; Zhu J; Liu Y; Yin Z; Wang L; Guo Y; Wang Z; Yan Q; Huang G
    BMC Cancer; 2011 Jul; 11():320. PubMed ID: 21798073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma.
    Min JK; Kim JM; Li S; Lee JW; Yoon H; Ryu CJ; Jeon SH; Lee JH; Kim JY; Yoon HK; Lee YK; Kim BH; Son YS; Choi HS; Lim NK; Kim DG; Hong HJ
    Clin Cancer Res; 2010 Jul; 16(14):3571-80. PubMed ID: 20501614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers.
    Ikeda H; Harada K; Sato Y; Sasaki M; Yoneda N; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Am J Clin Pathol; 2013 Sep; 140(3):329-40. PubMed ID: 23955451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of FOXP3 inhibits invasion and immune escape in cholangiocarcinoma.
    Ma C; Peng C; Lu X; Ding X; Zhang S; Zou X; Zhang X
    Biochem Biophys Res Commun; 2015 Mar; 458(2):234-9. PubMed ID: 25623530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells.
    Sangsuwannukul T; Supimon K; Sujjitjoon J; Phanthaphol N; Chieochansin T; Poungvarin N; Wongkham S; Junking M; Yenchitsomanus PT
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107069. PubMed ID: 33242709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
    Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.
    Wang M; Xiao J; Jiang J; Qin R
    Int J Cancer; 2011 Apr; 128(8):1996-7. PubMed ID: 20568110
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of hepatic stem/progenitor cells in canine hepatocellular and cholangiocellular carcinoma.
    Cogliati B; Aloia TP; Bosch RV; Alves VA; Hernandez-Blazquez FJ; Dagli ML
    Vet Comp Oncol; 2010 Jun; 8(2):112-21. PubMed ID: 20579324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma.
    Sugawara H; Yasoshima M; Katayanagi K; Kono N; Watanabe Y; Harada K; Nakanuma Y
    Histopathology; 1998 Aug; 33(2):145-53. PubMed ID: 9762547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma: preventing invasion as anti-cancer strategy.
    Gores GJ
    J Hepatol; 2003 May; 38(5):671-3. PubMed ID: 12713880
    [No Abstract]   [Full Text] [Related]  

  • 19. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
    Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
    Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.